Alzheon
0 followers
-
Performance
About Alzheon
Alzheon is a clinical-stage biopharmaceutical company developing disease-modifying medicines for Alzheimer's disease and other neurological disorders. It is advancing a Phase 3 program in Alzheimer’s disease and operates a discovery platform of small molecules focused on inhibiting protein misfolding and amyloid oligomer formation. The company emphasizes precision medicine, initially prioritizing APOE4 carriers, with plans to expand to broader patient populations. Alzheon conducts its research and development in the neurodegenerative diseases space, with activities spanning drug discovery, development, and clinical trials.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.